USPTO serial 87643534
Reviewed by CopyMark Law Group
Status 705 means a Madrid-based U.S. registration has accepted Section 71 maintenance and Section 15 incontestability. The U.S. extension is active with strengthened rights. Track next renewal deadlines in TSDR and WIPO records.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
ILLKIRCH-STRASBOURG, FR
ILLKIRCH-STRASBOURG, FR
ILLKIRCH-STRASBOURG, FR
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Jeffrey M. Goehring
Jeffrey M. Goehring Nixon & Vanderhye P.C.901 N. Glebe Road, 11th FloorArlington, VA 22203United States| Class | Description | Status | First use |
|---|---|---|---|
| 001 | [ Chemicals used in the biological, biotechnological, medical, pharmaceutical, and veterinary industries; biological preparations for use in the biological, biotechnological, medical, pharmaceutical, and veterinary industries ] | SECTION 8 - CANCELLED | — |
| 005 | [ Pharmaceutical and veterinary pharmaceutical preparations acting on the central nervous system; pharmaceutical and veterinary pharmaceutical preparations for treating cancer, neurologic diseases, psychiatric diseases, metabolic diseases, inflammatory diseases, cardiovascular diseases; pharmaceutical and veterinary pharmaceutical preparations for the treatment of pain ] | SECTION 8 - CANCELLED | — |
| 009 | [ Scientific apparatus and instruments, for the measurement of biological, pharmacological, psychological or chemical phenomena for performing cellular, phenotypic, biochemical, binding and functional assays ] | SECTION 8 - CANCELLED | — |
| 010 | [ Medical apparatus and instruments for targeting membrane proteins for tissue-based diagnostic testing, cytology and cell-based testing ] | SECTION 8 - CANCELLED | — |
| 042 | Scientific research and development relating to molecules for therapeutic use; scientific research and development relating to new procedures and experiments for discovering, identifying or improving molecules for therapeutic use; scientific laboratory and engineering services for developing molecule for therapeutic use | ACTIVE | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Mar 12, 2025 | NA85 | NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED | — |
| Mar 12, 2025 | C15P | REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. | — |
| Mar 12, 2025 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Nov 12, 2024 | E815 | TEAS SECTION 8 & 15 RECEIVED | — |
| Nov 6, 2023 | REM1 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | — |
| Mar 23, 2022 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Mar 23, 2022 | ECDR | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | — |
| Mar 23, 2022 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 23, 2022 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Nov 6, 2018 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Aug 21, 2018 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Aug 21, 2018 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Aug 1, 2018 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jul 12, 2018 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jul 11, 2018 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jul 11, 2018 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 11, 2018 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jan 23, 2018 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 23, 2018 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 23, 2018 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 22, 2018 | DOCK | ASSIGNED TO EXAMINER | — |
| Oct 21, 2017 | MDSC | NOTICE OF DESIGN SEARCH CODE E-MAILED | — |
| Oct 20, 2017 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Oct 16, 2017 | NWAP | NEW APPLICATION ENTERED | — |